sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Irritable Bowel Syndrome Treatment Market Scope And Analysis

  • Report Code : TIPRE00006814
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 180
Buy Now

Irritable Bowel Syndrome (IBS) Treatment Market Scope - 2031

Buy Now

Irritable Bowel Syndrome (IBS) Treatment Market Report Irritable Bowel Syndrome (IBS) Treatment Market Size and Share Irritable Bowel Syndrome (IBS) Treatment Market Scope and Analysis

Irritable Bowel Syndrome (IBS) Treatment Market Report Scope

Report Attribute Details
Market size in 2020 US$ 2.15 Billion
Market Size by 2028 US$ 4.6 Billion
Global CAGR (2020 - 2028) 10.1%
Historical Data 2018-2019
Forecast period 2021-2028
Segments Covered By Type
  • IBS with Diarrhea
  • IBS with Constipation
  • Mixed IBS
By Product
  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Linaclotide
By Distribution Channel
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Ironwood Pharmaceuticals Inc
  • AbbVie
  • Sebela Pharmaceuticals Inc
  • Takeda Pharmaceutical Company Limited
  • Alfasigma S p A
  • Astellas Pharma Inc
  • AstraZeneca
  • Synthetic Biologics Inc
  • Bausch Lomb Incorporated